Editor’s Choice

► Delray Beach-based answering service Call 4 Health celebrated its 20th year. ► Mike DeBock is the new president and CEO of the Economic Council of Palm Beach County. ►

Rachel Sapoznik promotes the power of wellness By Andrea Richard Rachel Sapoznik is just finishing up her Mediterranean salad, topped with grilled salmon, when she looks up and orders an

National Jets evolves into a one-stop shop for private aviation By Andrea Richard How companies survive and prosper depends on many variables. For National Jets, it’s all about personalized customer

By Stephen Garber The foundation of effective communication remains the same whether someone is speaking to an individual or to a group. The most important communication skill we can learn

Dear Mr. Berko: Amazon.com recently agreed to sell Nike products. Amazon can sell Nike’s merchandise for less than retail stores can, and according to my college professor, this is a

Dear Mr. Berko: I’m 83 and a conservative investor. My stockbroker of 21 years retired from his six-man firm, and my $166,000 individual retirement account isn’t big enough for Merrill

Dear Mr. Berko: In January 2010, you advised me to invest $10,000 in Boeing. I bought 157 shares at $63. Thanks to you, I’ve quadrupled my money, and the $5.68

Dear Mr. Berko: My wife and I are engineers, and we’re in our late 40s. In June 2015, you recommended a group of single-country exchange-traded funds, and we bought 800

By Kevin Gale and Andrea Richard Hurricane Irma is leaving a huge price tag in its wake with losses throughout the Southeastern United States that are estimated at $42.5 billion

The CEO of Henderson Behavioral Health, Dr. Steven Ronik, weighs in on game-changing advances in treatment, legislative concerns and much more. After 21 years as CEO at Henderson Behavioral Health,

Meteorologist Bryan Norcross looks back on the hurricane that devastated South Florida—and forever altered his career. It’s been 25 years since Bryan Norcross was in the right place at the

Dear Mr. Berko: In March 2013, I bought 500 shares of Nektar Therapeutics at $12. In March of this year, it traded at $24, but now it trades around $19.